The spectrum of glomerular disease between the years 2003 and 2015 in Columbia: A review of 12,613 cases.

Background: The prevalence of glomerular disease (GD) varies according to the different socio-demographic characteristics of each population. For the first time we present the prevalence of the different forms of GD among patients from several different areas of Columbia.

Methods: Data from 12,613 renal biopsies studied at our University Hospital between 2003 and 2015 was reviewed.

Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.

Gemcitabine is a medication used to treat various types of malignant neoplasms. Its association with hemolytic uremic syndrome (HUS) has been described in few cases, although these cases have resulted in mortality rates of at least 50%. We report on the case of a 25-year-old patient with cholangiocarcinoma in remission who developed microangiopathic hemolytic anemia with acute anuric renal failure after receiving 5 cycles of gemcitabine chemotherapy; this condition was consistent with HUS caused by the side effects of this drug.